Peter Attia· MD
especially in colon the progression from non-cancer to cancer is visible to the naked eye through the transition of non-malignant polyp to malignant polyp
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
especially in colon the progression from non-cancer to cancer is visible to the naked eye through the transition of non-malignant polyp to malignant polyp
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the progression from non-cancer to cancer is visible to the naked eye through the transition of non-malignant polyp to malignant polyp
What I've noticed being here is that the food quality is far and away better than in the States. I've heard the food in Europe is just totally different. And there's a farmers market at least once a week in every town I visited.
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.